Home » pharma analytics » Page 2

pharma analytics

Pharma Commercial Analytics: KPIs Every Brand Team Should Track

Pharma Commercial Analytics: KPIs Every Brand Team Should Track Pharma commercial teams operate in a highly competitive, fast moving market where every decision from targeting the right HCPs to optimizing patient support programs depends on accurate, timely data. Yet despite having access to massive datasets, brand teams often struggle to turn that information into actionable […]

Pharma Commercial Analytics: KPIs Every Brand Team Should Track Read More »

Why Every Specialty Pharma Needs a Centralized Data Hub

Why Every Specialty Pharma Needs a Centralized Data Hub In the world of specialty pharma, data is everywhere coming from prescribers, pharmacies, patient support programs, payers, and distribution networks. Yet, most organizations struggle to see the complete picture. Insights live in silos, reports take weeks to compile, and critical business decisions are often made with

Why Every Specialty Pharma Needs a Centralized Data Hub Read More »

The Access KPI Misalignment: Tracking What Looks Good vs. What Moves the Needle

The Access KPI Misalignment: Tracking What Looks Good vs. What Moves the Needle In today’s pharma landscape, patient access is one of the most critical levers for success. Yet, too often, the industry gets caught up in tracking the wrong metrics. Teams celebrate “good looking” numbers like high call volumes or hub enrollments, but these

The Access KPI Misalignment: Tracking What Looks Good vs. What Moves the Needle Read More »

The 60% Blind Spot: Why Most Patient Services Data Never Informs Decisions

The 60% Blind Spot: Why Most Patient Services Data Never Informs Decisions Pharmaceutical companies today invest heavily in patient services programs covering access support, copay assistance, adherence monitoring, and more. These initiatives generate mountains of patient level data, ranging from prescription fill rates to call center interactions. Yet, research shows that up to 60% of

The 60% Blind Spot: Why Most Patient Services Data Never Informs Decisions Read More »